Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-01-13

Clinical Trial Update: Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial validating ultrasound biomarkers for hepatic sinusoidal obstruction syndrome in pediatric hematopoietic cell transplant patients has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Sinusoidal Obstruction Syndrome, Veno Occlusive Disease, Hepatic | Phase 4 | Status: WITHDRAWN